Flolan

Active Ingredient(s): Epoprostenol
FDA Approved: * September 20, 1995
Pharm Company: * GLAXOSMITHKLINE
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Flolan Overview

Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator. When used as a drug, it is also known as epoprostenol.[1] The terms are sometimes used interchangeably.[2] Contents 1 Function 2 Medical uses 3 Degradation 4 Mechanism 5 Members[7] 6 Pharmacology 7 Synthesis 7.1 Biosynthesis 7.2 Artificial synthesis 8...

Read more Flolan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Prostacyclin

Recent Flolan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Flolan: (4 results)

Sorted by National Drug Code

• 0173-0517 Flolan .5 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline LLC
• 0173-0519 Flolan 1.5 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline LLC
• 12064-011 Flolan .5 mg Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa
• 12064-012 Flolan 1.5 mg Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa

Other drugs which contain Epoprostenol or a similar ingredient: (1 result)

• EPOPROSTENOL

Related Flolan Topics: